Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Gates partners with Immunocore

Country: United Kingdom

The Bill & Melinda Gates Foundation is to invest up to $40 million in Immunocore Ltd to support the development of the company’s T cell receptor technology (TCR) for infectious disease. The UK company already has partnerships exploring TCRs against cancer.

Read more

New guselkumab data in plaque psoriasis

Country: United States

New longer-term data from a Phase 3 trial of the drug guselkumab for plaque psoriasis has shown that patients achieved consistent rates of skin clearance following treatment at both 52 and 100 weeks, according to the developer Janssen Research & Development LLC.

Read more

EMA recommends two new cancer drugs

Country: United Kingdom

Read more

Genenta raises €7 million in Series B round

Country: Italy

Read more

Novo to pay $58.65 million to settle probe

Country: Denmark

Read more

Prostvac trial declared futile

Country: Denmark

Read more

Kåre Schultz to take charge at Teva Pharmaceutical

Country: Denmark

Read more

Merck to acquire Rigontec

Country: Germany

Read more

Gene therapy trial featured

Country: United States

Read more

Nightstar plans $86 million US offering

Country: United Kingdom

Read more

FDA approves Novartis CAR T therapy

Country: United States

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

How artificial intelligence is changing drug discovery

ArtificialintelligenceSept2017.pdf

Highlights of the September 2017 MedNous issue

The September 2017 MedNous features:

Latest Mednous cover
  • Business Strategy
    How artificial intelligence
    is changing drug discovery
  • Research Strategy
    Novel immunotherapy arises from collaboration
    By Andrea van Elsas
  • Oncology Review
    Long-term strategies for immuno-oncology
    By Bruno Pagliara
  • MedNous Briefing
    EU examines incentives for the pharma industry
    By Jane Morrison
  • Stock Market Commentary
    A phenotypic share analysis
    By William Ellington

The latest MedNous journal. Subscribe to download.